Fatal Pancytopenia in a Hemodialysis Patient After Treatment With Low-Dose Methotrexate
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要We report a 56-year-old male hemodialysis patient who developed fatal pancytopenia after treatment with low-dose methotrexate for psoriasis and psoriatic arthropathy. Risk factors identified included impaired renal function, concurrent use of nonsteroidal anti-inflammatory drugs, low serum albumin, and relatively low serum folate level. Literature review found similar risk factors in 12 other cases. Therefore, methotrexate, even as a single dose, should not be used to treat rheumatic conditions in dialysis patients.
著者Cheung KKT, Chow KM, Szeto CC, Tai MHL, Kwan BCH, Li PKT
期刊名稱JCR: Journal of Clinical Rheumatology
出版年份2009
月份6
日期1
卷號15
期次4
出版社Lippincott, Williams & Wilkins
頁次177 - 180
國際標準期刊號1076-1608
語言英式英語
關鍵詞dialysis; methotrexate; pancytopenia; renal failure
Web of Science 學科類別Rheumatology; RHEUMATOLOGY

上次更新時間 2021-25-02 於 00:06